| UniProt ID | M3K3_HUMAN | |
|---|---|---|
| UniProt AC | Q99759 | |
| Protein Name | Mitogen-activated protein kinase kinase kinase 3 | |
| Gene Name | MAP3K3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 626 | |
| Subcellular Localization | ||
| Protein Description | Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.. | |
| Protein Sequence | MDEQEALNSIMNDLVALQMNRRHRMPGYETMKNKDTGHSNRQSDVRIKFEHNGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYMNNELSILLKNQDDLDKAIDILDRSSSMKSLRILLLSQDRNHNSSSPHSGVSRQVRIKASQSAGDINTIYQPPEPRSRHLSVSSQNPGRSSPPPGYVPERQQHIARQGSYTSINSEGEFIPETSEQCMLDPLSSAENSLSGSCQSLDRSADSPSFRKSRMSRAQSFPDNRQEYSDRETQLYDKGVKGGTYPRRYHVSVHHKDYSDGRRTFPRIRRHQGNLFTLVPSSRSLSTNGENMGLAVQYLDPRGRLRSADSENALSVQERNVPTKSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGRDFLRRIFVEARQRPSAEELLTHHFAQLMY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 28 | Phosphorylation | RRHRMPGYETMKNKD HHCCCCCCHHCCCCC | 11.45 | 29083192 | |
| 30 | Phosphorylation | HRMPGYETMKNKDTG CCCCCCHHCCCCCCC | 25.59 | 29083192 | |
| 36 | Phosphorylation | ETMKNKDTGHSNRQS HHCCCCCCCCCCCCC | 38.10 | 22210691 | |
| 39 | Phosphorylation | KNKDTGHSNRQSDVR CCCCCCCCCCCCCEE | 34.74 | 22210691 | |
| 50 (in isoform 2) | Phosphorylation | - | 31.29 | 24275569 | |
| 55 (in isoform 2) | Phosphorylation | - | 36.17 | 25159151 | |
| 57 (in isoform 2) | Phosphorylation | - | 3.14 | 24275569 | |
| 59 (in isoform 2) | Phosphorylation | - | 8.26 | 24275569 | |
| 102 | Ubiquitination | KNQDDLDKAIDILDR CCHHHHHHHHHHHHH | 55.31 | - | |
| 122 | Phosphorylation | SLRILLLSQDRNHNS HHHHHHHCCCCCCCC | 29.97 | 29214152 | |
| 129 | Phosphorylation | SQDRNHNSSSPHSGV CCCCCCCCCCCCCCC | 25.33 | 27732954 | |
| 130 | Phosphorylation | QDRNHNSSSPHSGVS CCCCCCCCCCCCCCC | 53.88 | 18691976 | |
| 131 | Phosphorylation | DRNHNSSSPHSGVSR CCCCCCCCCCCCCCH | 26.84 | 26055452 | |
| 134 | Phosphorylation | HNSSSPHSGVSRQVR CCCCCCCCCCCHHHE | 44.25 | 27732954 | |
| 137 | Phosphorylation | SSPHSGVSRQVRIKA CCCCCCCCHHHEEEE | 22.11 | 27732954 | |
| 145 | Phosphorylation | RQVRIKASQSAGDIN HHHEEEECCCCCCCC | 21.48 | 21945579 | |
| 147 | Phosphorylation | VRIKASQSAGDINTI HEEEECCCCCCCCCC | 31.55 | 21945579 | |
| 153 | Phosphorylation | QSAGDINTIYQPPEP CCCCCCCCCCCCCCC | 22.77 | 21945579 | |
| 155 | Phosphorylation | AGDINTIYQPPEPRS CCCCCCCCCCCCCCC | 16.96 | 21945579 | |
| 162 | Phosphorylation | YQPPEPRSRHLSVSS CCCCCCCCCCCCCCC | 34.46 | 18691976 | |
| 162 (in isoform 2) | Phosphorylation | - | 34.46 | 27251275 | |
| 166 | Phosphorylation | EPRSRHLSVSSQNPG CCCCCCCCCCCCCCC | 17.52 | 23401153 | |
| 168 | Phosphorylation | RSRHLSVSSQNPGRS CCCCCCCCCCCCCCC | 23.88 | 22115753 | |
| 169 | Phosphorylation | SRHLSVSSQNPGRSS CCCCCCCCCCCCCCC | 31.64 | 23401153 | |
| 175 | Phosphorylation | SSQNPGRSSPPPGYV CCCCCCCCCCCCCCC | 53.78 | 23401153 | |
| 176 | Phosphorylation | SQNPGRSSPPPGYVP CCCCCCCCCCCCCCC | 39.81 | 23401153 | |
| 176 (in isoform 2) | Phosphorylation | - | 39.81 | 27642862 | |
| 178 (in isoform 2) | Phosphorylation | - | 36.58 | 24719451 | |
| 181 | Phosphorylation | RSSPPPGYVPERQQH CCCCCCCCCCHHHHH | 20.71 | 23403867 | |
| 186 (in isoform 2) | Phosphorylation | - | 37.23 | 27642862 | |
| 194 | Phosphorylation | QHIARQGSYTSINSE HHHHHCCCCCEECCC | 19.52 | - | |
| 197 | Phosphorylation | ARQGSYTSINSEGEF HHCCCCCEECCCCCC | 16.13 | 18691976 | |
| 197 (in isoform 2) | Phosphorylation | - | 16.13 | 24719451 | |
| 199 (in isoform 2) | Phosphorylation | - | 33.50 | 24719451 | |
| 200 (in isoform 2) | Phosphorylation | - | 45.36 | 27251275 | |
| 207 (in isoform 2) | Phosphorylation | - | 61.21 | 24719451 | |
| 234 | Phosphorylation | SCQSLDRSADSPSFR CHHHCCCCCCCHHHH | 35.77 | 17192257 | |
| 237 | Phosphorylation | SLDRSADSPSFRKSR HCCCCCCCHHHHHHH | 23.35 | 23401153 | |
| 239 | Phosphorylation | DRSADSPSFRKSRMS CCCCCCHHHHHHHHH | 41.45 | 23403867 | |
| 250 | Phosphorylation | SRMSRAQSFPDNRQE HHHHHHHHCCCCHHH | 37.45 | 23401153 | |
| 259 | Phosphorylation | PDNRQEYSDRETQLY CCCHHHHCHHCCHHH | 29.46 | 23186163 | |
| 263 | Phosphorylation | QEYSDRETQLYDKGV HHHCHHCCHHHHCCC | 25.43 | 24719451 | |
| 266 | Phosphorylation | SDRETQLYDKGVKGG CHHCCHHHHCCCCCC | 13.04 | 24719451 | |
| 268 (in isoform 2) | Phosphorylation | - | 52.63 | 24719451 | |
| 274 | Phosphorylation | DKGVKGGTYPRRYHV HCCCCCCCCCCEEEE | 38.73 | 28102081 | |
| 275 | Phosphorylation | KGVKGGTYPRRYHVS CCCCCCCCCCEEEEE | 9.68 | 28102081 | |
| 281 (in isoform 2) | Phosphorylation | - | 4.79 | 24719451 | |
| 288 | Phosphorylation | VSVHHKDYSDGRRTF EEEECCCCCCCCCCC | 17.29 | 23403867 | |
| 289 | Phosphorylation | SVHHKDYSDGRRTFP EEECCCCCCCCCCCC | 43.66 | 23403867 | |
| 294 | Phosphorylation | DYSDGRRTFPRIRRH CCCCCCCCCCCCEEC | 36.31 | 23401153 | |
| 294 (in isoform 2) | Phosphorylation | - | 36.31 | 24719451 | |
| 297 (in isoform 2) | Phosphorylation | - | 30.75 | 24719451 | |
| 305 (in isoform 2) | Phosphorylation | - | 4.42 | 24719451 | |
| 306 (in isoform 2) | Phosphorylation | - | 6.02 | 24719451 | |
| 311 | Phosphorylation | NLFTLVPSSRSLSTN CEEEECCCCCCCCCC | 30.79 | 25849741 | |
| 312 | Phosphorylation | LFTLVPSSRSLSTNG EEEECCCCCCCCCCC | 21.59 | 25849741 | |
| 314 | Phosphorylation | TLVPSSRSLSTNGEN EECCCCCCCCCCCCC | 28.72 | 22617229 | |
| 316 | Phosphorylation | VPSSRSLSTNGENMG CCCCCCCCCCCCCCE | 22.52 | 22115753 | |
| 317 | Phosphorylation | PSSRSLSTNGENMGL CCCCCCCCCCCCCEE | 53.16 | 27273156 | |
| 325 (in isoform 2) | Phosphorylation | - | 4.80 | 27251275 | |
| 337 | Phosphorylation | DPRGRLRSADSENAL CCCCCCCCCCCCCCC | 40.81 | 27273156 | |
| 340 | Phosphorylation | GRLRSADSENALSVQ CCCCCCCCCCCCCHH | 32.25 | 29255136 | |
| 343 (in isoform 2) | Phosphorylation | - | 9.36 | 27251275 | |
| 345 | Phosphorylation | ADSENALSVQERNVP CCCCCCCCHHHCCCC | 21.24 | 23403867 | |
| 345 (in isoform 2) | Phosphorylation | - | 21.24 | 24719451 | |
| 348 (in isoform 2) | Phosphorylation | - | 44.03 | 27251275 | |
| 353 | Phosphorylation | VQERNVPTKSPSAPI HHHCCCCCCCCCCCC | 39.61 | 23403867 | |
| 355 | Phosphorylation | ERNVPTKSPSAPINW HCCCCCCCCCCCCCC | 26.94 | 23401153 | |
| 357 | Phosphorylation | NVPTKSPSAPINWRR CCCCCCCCCCCCCCC | 54.49 | 28102081 | |
| 366 | Ubiquitination | PINWRRGKLLGQGAF CCCCCCCCCCCCCCC | 38.43 | - | |
| 368 (in isoform 2) | Phosphorylation | - | 5.69 | 24719451 | |
| 371 (in isoform 2) | Phosphorylation | - | 22.52 | 24719451 | |
| 384 | Phosphorylation | YLCYDVDTGRELASK EEEEECCCCCCHHHH | 37.68 | 18691976 | |
| 386 (in isoform 2) | Phosphorylation | - | 37.54 | 24719451 | |
| 391 | Ubiquitination | TGRELASKQVQFDPD CCCCHHHHCCCCCCC | 49.21 | - | |
| 397 (in isoform 2) | Ubiquitination | - | 45.31 | - | |
| 404 | Ubiquitination | PDSPETSKEVSALEC CCCCCHHHHHHHHHH | 70.34 | - | |
| 417 | Ubiquitination | ECEIQLLKNLQHERI HHHHHHHHHCCHHHH | 65.29 | - | |
| 427 | Phosphorylation | QHERIVQYYGCLRDR CHHHHHHHHHHHHHH | 7.31 | 18083107 | |
| 428 | Phosphorylation | HERIVQYYGCLRDRA HHHHHHHHHHHHHHH | 5.58 | 18083107 | |
| 438 | Phosphorylation | LRDRAEKTLTIFMEY HHHHHHHHEEEEEEC | 22.19 | 29759185 | |
| 440 | Phosphorylation | DRAEKTLTIFMEYMP HHHHHHEEEEEECCC | 19.87 | 29759185 | |
| 445 | Phosphorylation | TLTIFMEYMPGGSVK HEEEEEECCCCCCHH | 9.23 | 29759185 | |
| 456 | Ubiquitination | GSVKDQLKAYGALTE CCHHHHHHHHCCCCH | 33.65 | - | |
| 458 | Phosphorylation | VKDQLKAYGALTESV HHHHHHHHCCCCHHH | 11.01 | 28152594 | |
| 464 | Phosphorylation | AYGALTESVTRKYTR HHCCCCHHHHHHHHH | 24.45 | 19060867 | |
| 470 | Phosphorylation | ESVTRKYTRQILEGM HHHHHHHHHHHHHHH | 21.09 | 24719451 | |
| 482 | Phosphorylation | EGMSYLHSNMIVHRD HHHHHHHCCCEECCC | 26.04 | 24719451 | |
| 491 | Ubiquitination | MIVHRDIKGANILRD CEECCCCCCCCCEEC | 57.15 | - | |
| 499 | Phosphorylation | GANILRDSAGNVKLG CCCCEECCCCCEECC | 31.48 | 23403867 | |
| 504 | Ubiquitination | RDSAGNVKLGDFGAS ECCCCCEECCCCCCC | 51.24 | - | |
| 511 | Phosphorylation | KLGDFGASKRLQTIC ECCCCCCCCCCEEEE | 20.77 | - | |
| 512 | Ubiquitination | LGDFGASKRLQTICM CCCCCCCCCCEEEEE | 57.50 | - | |
| 516 | Phosphorylation | GASKRLQTICMSGTG CCCCCCEEEEECCCC | 22.27 | 20448038 | |
| 520 | Phosphorylation | RLQTICMSGTGMRSV CCEEEEECCCCCCCC | 28.88 | 20448038 | |
| 526 | Phosphorylation | MSGTGMRSVTGTPYW ECCCCCCCCCCCCCC | 18.35 | 26657352 | |
| 528 | Phosphorylation | GTGMRSVTGTPYWMS CCCCCCCCCCCCCCC | 36.26 | 28857561 | |
| 530 | Phosphorylation | GMRSVTGTPYWMSPE CCCCCCCCCCCCCCE | 12.11 | 28857561 | |
| 557 (in isoform 2) | Phosphorylation | - | 3.90 | 27251275 | |
| 590 | Phosphorylation | PTNPQLPSHISEHGR CCCCCCCHHHHHHHH | 41.88 | 26307563 | |
| 593 | Phosphorylation | PQLPSHISEHGRDFL CCCCHHHHHHHHHHH | 20.37 | 26307563 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 166 | S | Phosphorylation | Kinase | SGK1 | O00141 | Uniprot |
| 166 | S | Phosphorylation | Kinase | SGK-FAMILY | - | GPS |
| 166 | S | Phosphorylation | Kinase | SGK_GROUP | - | PhosphoELM |
| 337 | S | Phosphorylation | Kinase | SGK1 | O00141 | Uniprot |
| 337 | S | Phosphorylation | Kinase | SGK-FAMILY | - | GPS |
| 337 | S | Phosphorylation | Kinase | SGK_GROUP | - | PhosphoELM |
| 526 | S | Phosphorylation | Kinase | MAP3K3 | Q99759 | GPS |
| - | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:24975362 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M3K3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337 AND SER-340, ANDMASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; SER-130; SER-145;SER-147; SER-166; SER-168; SER-175; SER-176; SER-237; SER-250;SER-311; SER-314; SER-316; THR-317; SER-337; SER-340; THR-353;SER-355; SER-464 AND SER-526, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-166; SER-234;SER-237; SER-250; SER-337; SER-340 AND SER-355, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-288; SER-289 ANDTHR-294, AND MASS SPECTROMETRY. | |
| "Inhibition of mitogen-activated kinase kinase kinase 3 activitythrough phosphorylation by the serum- and glucocorticoid-inducedkinase 1."; Chun J., Kwon T., Kim D.J., Park I., Chung G., Lee E.J., Hong S.K.,Chang S.I., Kim H.Y., Kang S.S.; J. Biochem. 133:103-108(2003). Cited for: PHOSPHORYLATION AT SER-166 AND SER-337 BY SGK1. | |